We hypothesized that patients with VTE and active cancer would show the highest values of both EV-TF and IL-6 because of the concurrent presence of these two potential procoagulant and proinflammatory conditions, such as active cancer and acute thrombosis. This evidence concerns the gene TF and cancer.